Semaglutide shows promise in treating knee osteoarthritis by reducing pain and weight, offering a safe alternative to traditional pharmacological interventions.

A groundbreaking study shows that the weight-loss drug semaglutide can significantly reduce knee pain from obesity-related arthritis, offering a new non-opioid option for pain relief. However, experts warn of potential challenges such as weight regain after stopping the drug and its high cost.